Sinew Pharma, Inc. engages in the research and development of drugs related to liver disease treatment and pain treatment. It develops acetaminophen, drugs for non-alcoholic steatohepatitis, and acetaminophen poisoning antidotes. The company was founded by Kai Min Chu on June 18, 2014 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company